Newsletters
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
AMR Action Fund: A $1b down payment from Industry; A call for creation of strong Pull incentives
“The world is changed by your example, not by your opinion” (Paulo Coelho) Dear All, The AMR Action Fund (https://www.amractionfund.com/) ...
Read More >
Draft FDA guidance on anti-infectives for children: It’s (mostly) all about PK and safety
Dear All (wonkish alert … the first 3 segments are non-wonkish but the last 2 are in the wonkish zone ...
Read More >
FDA: Early endpoints and late endpoints suggest a path to global regulatory convergence (Bart et al.)
Dear All (wonkish note alert … top-up your coffee and settle in!), Today we have a tour of a recent ...
Read More >
FDA analysis of 40-years of antibacterial development: Dheman et al.
Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter), Just out in CID is a paper in ...
Read More >
SPIDAAR & ATLAS: Data sharing via AMR Surveillance partnerships
Dear All, Building on the ATLAS database (link) that provides open access to data from 2004 to the present out ...
Read More >
Six-month consultancy with WHO to support antibiotic stewardship
Dear All, Wow, a news-heavy day … at least two more newsletters this weekend, I think. See below my signature ...
Read More >
SAVE THE DATE: 9 July launch of a major global AMR Initiative
(Updated on 8 July 2020) Dear All, Mark your calendars now for a major global AMR initiative that will be ...
Read More >
Final CABP and HABP-VABP guidances from FDA; EU seeks to accelerate access to medicines
Dear All, Some regulatory updates today. From FDA, we have final versions of their CABP and HABP-VABP guidance documents. My ...
Read More >
NHS England Antibiotic Procurement Pilot: Call for applications!
Dear All, As has been discussed in recent newsletters (link), the UK National Institute for Health and Care Excellence (NICE) ...
Read More >
National Academies: Nominations sought for ad hoc committee on medical and economic impact of AMR
26 Aug 2020 update: The committe has been named and some additional project commentary posted. Go here for details. — ...
Read More >
Perspectives on restoring the antibiotic ecosystem: ACS ID, June 2020 issue
Dear All, The June issue of ACS Infectious Diseases (link) is entirely devoted to the perspectives on how we can ...
Read More >
Jobs (mostly in Denmark) supporting global implementation of National Action Plans
Dear All, As recently highlighted in the 2019 reports from the World Bank (Pulling Together to Beat Superbugs, link) and ...
Read More >
Novo REPAIR Impact Fund: Global call is open through 31 July 2020
Dear All, Sharpen your pencils! The Novo REPAIR Impact Fund has just opened its 2020 call for proposals. The focus ...
Read More >
Assessing antibiotic value: DTR, fire extinguishers, and a view from Australia
Dear All (wonkish note alert — refresh your coffee before proceeding — with thanks to Kevin Outterson for co-authoring this ...
Read More >
Tender call: Global AMR R&D Hub seeks analyses of the market potential of four types of AMR products
Dear All, The G20-sponsored Global AMR R&D Hub (https://globalamrhub.org/) has recently published a call requesting proposals to estimate the market ...
Read More >
Virtual collaborations: JPIAMR’s Virtual Research Initiative; Global AMR Hub’s Dashboard
Dear All, If there is a silver lining to the dark cloud of COVID-19, it’s that we’re all becoming very ...
Read More >
From an IV arsenical to PO fexinidazole for Sleeping Sickness: A doctor’s dream
Dear All, As those of us who have had the privilege of standing at the bedside and delivering care know ...
Read More >
Timely guidelines, regularly updated: COVID-19, C. difficile, and beyond
Dear All, During the 18-19 Nov 2019 FDA-IDSA-NIAID-Pew workshop on ways to enhance antibacterial research (link), we spent some time ...
Read More >
WHO 2020 preclinical antibacterial pipeline data call
Dear All: As you will hopefully recall from November 2019, Theuretzbacher et al. published a review of the preclinical pipeline ...
Read More >
Movies to discover antibiotics by!
Dear All, Well, I think we can all agree that being grounded and shut away by COVID-19 is not exactly ...
Read More >
